Topic: Breaking Research News from sources other than Breastcancer.org

Forum: Clinical Trials, Research News, Podcasts, and Study Results — Share your research articles, interpretations and experiences here. Let us know how these studies affect you and your decisions.

Posted on: Nov 20, 2017 10:31PM - edited Nov 20, 2017 10:35PM by lumpie

Posted on: Nov 20, 2017 10:31PM - edited Nov 20, 2017 10:35PM by lumpie

lumpie wrote:

I watch for research news on breast cancer, treatments, etc., and frequently see interesting articles. There is a topic on BCO called "Breaking Research News from Breastcancer.org." One of the moderators suggested that another topic might be appropriate for posting links and synopses of reports on research found elsewhere. So here it is! Please post links to reports on research form reliable sources. Thanks for sharing!

"We must be willing to let go of the life we have planned, so as to have the life that is waiting for us." "If adventures will not befall a young lady in her own village, she must seek them abroad." "Buy the ticket, take the ride." Dx 2015, DCIS/IDC, Right, 3cm, Stage IIA, Grade 3, 0/1 nodes, ER-/PR-, HER2- Chemotherapy 1/13/2016 Cytoxan (cyclophosphamide), Taxotere (docetaxel) Targeted Therapy 1/14/2016 Herceptin (trastuzumab) Dx 2017, IDC, Stage IV, metastasized to liver, ER-/PR-, HER2- Surgery Lumpectomy; Lumpectomy (Right) Surgery Lumpectomy; Lumpectomy (Right) Radiation Therapy Whole breast: Breast
Log in to post a reply

Page 310 of 312 (3,111 results)

Log in to post a reply

Sep 17, 2022 02:14PM minustwo wrote:

Yes, thanks Debbie.

And always thanks to Lumpie, who continues to make this thread such a valuable place to go.

2/15/11 BMX-DCIS 2SNB clear-TEs; 9/15/11-410gummies; 3/20/13 recurrance-5.5cm,mets to lymphs, Stage IIIB IDC ER/PRneg,HER2+; TCH/Perjeta/Neulasta x6; ALND 9/24/13 1/18 nodes 4.5cm; AC chemo 10/30/13 x3; herceptin again; Rads Feb2014
Log in to post a reply

Oct 1, 2022 05:36AM - edited Oct 1, 2022 10:56AM by debbew

[Basic research in mice] Cancer cells 'hijack' a process used by healthy cells to spread around the body, research finds

https://www.news-medical.net/news/20220929/Cancer-...


Log in to post a reply

Oct 1, 2022 05:44AM - edited Oct 1, 2022 10:57AM by debbew

[Basic research in mice] Altered fat cells may fuel breast cancer tumor growth

https://www.medicalnewstoday.com/articles/altered-...


Log in to post a reply

Oct 1, 2022 05:54AM - edited Oct 1, 2022 10:57AM by debbew

[Basic research in mice] Unhealthy Gut May Set the Stage for Breast Cancer to Spread, Preclinical Research Reveals

https://ascopost.com/news/september-2022/unhealthy...


Log in to post a reply

Oct 1, 2022 08:32AM threetree wrote:

Debbew - Thanks as always for these references. I'd just seen references to the first two on ScienceDirect I think, but the 3rd one I hadn't and I think it is the most interesting. It would seem to make a case for all that probiotic sauerkraut and yogurt that I eat (smile).

Log in to post a reply

Oct 7, 2022 11:18AM debbew wrote:

[preclinical research potentially leading to a trial] A new mechanism of drug resistance discovered for breast cancer

https://medicalxpress.com/news/2022-10-mechanism-d...


Log in to post a reply

Oct 14, 2022 08:22AM debbew wrote:

Not exactly news, but a good overview of emerging drugs currently in trials:

https://www.targetedonc.com/view/emerging-therapie...


Log in to post a reply

Oct 15, 2022 04:19AM rah2464 wrote:

Debbew thanks for posting the article. Very informative and makes you hopeful to see so many new medications being developed.

Dx 5/23/2018, IDC, Left, 1cm, Stage IA, Grade 2, 0/4 nodes, ER+/PR+, HER2- Surgery 6/26/2018 Mastectomy; Mastectomy (Left); Mastectomy (Right); Reconstruction (Left): Silicone implant; Reconstruction (Right): Silicone implant Hormonal Therapy 7/26/2018 Tamoxifen pills (Nolvadex, Apo-Tamox, Tamofen, Tamone)
Log in to post a reply

Nov 2, 2022 05:59AM debbew wrote:

ER Antagonist OP-1250 Demonstrates Continued Anti-Tumor Activity in Advanced ER+ HER2– Breast Cancer

"The results we presented today from our monotherapy dose expansion study provide further validation of our belief in OP-1250's potential to become the endocrine therapy of choice for [ER-positive] breast cancer. OP-1250 has a compelling profile for a CERAN/SERD as it is well-tolerated, achieves high drug exposure, and has demonstrated encouraging efficacy across both wild-type and ESR1 mutant tumors," Sean P. Bohen, MD, PhD, president and chief executive officer at Olema Oncology, said in the press release. "Our mission is to transform the breast cancer treatment landscape and to develop therapies that offer the potential to improve outcomes for women living with cancer. We believe in the potential of OP-1250, and we look forward to initiating our first pivotal Phase 3 trial mid-next year."

https://www.cancernetwork.com/view/er-antagonist-o...

Log in to post a reply

Nov 2, 2022 11:43AM maggie15 wrote:

Debbew: Thanks for posting. Due to a rare complication caused by radiation most bc treatments are off the table for me because of possible SEs. SERD/CERANs is one of the few med classes I could use so it is good to know about the ongoing research and development in this area.

DX 2/15/2021, IDC, Right, 3 cm, stage 2A, ER+/PR+, HER2-

Page 310 of 312 (3,111 results)

Scroll to top button